2025 EPS consensus $2.21. Lowers 2025 revenue view to $1.62B-$1.64B from $1.655B-$1.68B, consensus $1.67B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IART:
- IART Upcoming Earnings Report: What to Expect?
- Integra LifeSciences’ Innovative Approach to Ulcer Treatment: A Study Update
- Integra LifeSciences Advances with MIRROR Registry Study on Hematoma Evacuation
- Integra LifeSciences’ Pediatric Study: A Real-World Evaluation of the AERA® Device
- Integra LifeSciences’ New Study on Burn Treatment: What Investors Need to Know